KALVISTA PHARMACEUTICALS INC

Ticker: KALV CUSIP: 483497103 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 22,949 Value ($000) $266 Avg Close $12.58 Range $9.45 - $15.50
Q2 2024
Shares 10,704 Value ($000) $126 Avg Close $11.67 Range $10.11 - $12.92
Q1 2024
Shares 68,205 Value ($000) $809 Avg Close $13.33 Range $10.70 - $16.88
Q4 2023
Shares 110,922 Value ($000) $1,359 Avg Close $9.10 Range $7.21 - $12.74
Q3 2023
Shares 104,668 Value ($000) $1,008 Avg Close $10.22 Range $8.76 - $11.45
Q2 2023
Shares 107,975 Value ($000) $972 Avg Close $9.22 Range $7.53 - $10.95
Q1 2023
Shares 99,871 Value ($000) $785 Avg Close $7.46 Range $6.20 - $8.54
Q4 2022
Shares 93,413 Value ($000) $631 Avg Close $5.36 Range $4.12 - $14.73
Q3 2022
Shares 95,586 Value ($000) $1,387 Avg Close $13.98 Range $9.49 - $17.06
Q2 2022
Shares 65,882 Value ($000) $648 Avg Close $11.03 Range $8.00 - $15.59
Q1 2022
Shares 22,893 Value ($000) $337 Avg Close $14.37 Range $10.79 - $17.34
Q4 2021
Shares 16,048 Value ($000) $212 Avg Close $15.92 Range $11.99 - $18.53
Q3 2021
Shares 11,887 Value ($000) $207 Avg Close $20.27 Range $16.86 - $24.80